A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Eli Lilly and Company
Nektar Therapeutics
Eli Lilly and Company
Georgetown University
Centro Nacional de Investigaciones Oncologicas CARLOS III
Eli Lilly and Company